Browsing: Bio Tech & Pharma
Key results include: For the second quarter, total revenues increased 20% to $8.4 billion in comparison to the second quarter…
Financial Results Delivered record revenues of $95,573, an increase of $5,668 or 6% over the same period in prior year…
A recent analysis indicates that market indices are anticipating a rate cut in September, reflecting optimism for the economy. The…
In a statement by Professor Dana Rizk, an Investigator and APPLAUSE-IgAN Steering Committee Member at the University of Alabama at…
Professor Dana Rizk, an Investigator and APPLAUSE-IgAN Steering Committee Member at the University of Alabama at Birmingham Division of Nephrology,…
The complex and progressive nature of IgA nephropathy poses challenges in its effective treatment, but the landscape of therapies is…
The Phase 1a trial of SZN-043 has shown evidence of target engagement and Wnt-pathway mediated pharmacodynamic effects in the liver.…
The Phase 1a trial of SZN-043 showed evidence of target engagement and Wnt-pathway mediated pharmacodynamic effects in the liver. Enrollment…
A Phase 1a trial of SZN-043 has shown promising results, indicating target engagement and Wnt-pathway mediated pharmacodynamic effects in the…
Valeo Pharma Inc (TSX: VPH), a Canadian pharmaceutical company, recently announced a 3% increase in revenues for the three-month period…